---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-022624"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:15:03.215432+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma closes $49,200 convertible note financing with 15% interest, net $41,000

## Summary
- Entered securities purchase agreement with 1800 Diagonal Lending LLC for $49,200 convertible note; purchase price $41,000 (includes $8,200 OID).
- Note matures March 30, 2025; one-time 15% interest, total payback $56,580 due in five installments starting Nov 30, 2024.
- Upon event of default, investor may convert at 65% of lowest trading price in prior 10 days (35% discount).
- Proceeds used for general working capital; issuance exempt under Section 4(a)(2) and Rule 506 of Regulation D.
- Company has approximately 183.3 million shares of common stock outstanding as of May 22, 2024.

## SEC filing metadata
- accession: 0001493152-24-022624
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224022624/0001493152-24-022624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224022624/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-022624
- JSON: https://secwatch.observer/filing/0001493152-24-022624.json
- Plain text: https://secwatch.observer/filing/0001493152-24-022624.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.